ERY-VAX

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameERY-VAX

Drug Alias NameERYMMUNE

ClassificationCell and gene therapy > Cell therapy > Somatic cell > Erythrocyte therapyBiologics > Antigen > Tumor antigenVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsYes

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesPhaxiam Therapeutics SA

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesPhaxiam Therapeutics SA

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A